《大行報告》一表列出花旗挑選受惠本港放寬入境檢疫措施股份名單
本港自今日(26日)起自海外或台灣機場入境檢疫改「0+3」(即取消酒店強制檢疫,只需三日居家醫學監測),登機前快測取代核酸檢測,而來港易及回港易計劃將不設限額,該行挑選及列出相關受惠股份名單:
股份
匯豐控股(00005.HK)
友邦(01299.HK)
銀河娛樂(00027.HK)
金沙中國(01928.HK)
領展(00823.HK)
太古A(00019.HK)
周大福(01929.HK)
六福(00590.HK)
利福(01212.HK)
莎莎國際(00178.HK)
香格里拉(亞洲)(00069.HK)
香港中旅(00308.HK)
牛奶國際(DFIR.SI)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.